Select an Online Manual
THE MERCK MANUAL MEDICAL LIBRARY: The Merck Manual of Diagnosis and Therapy
Tips for better results
ABCDEFGHI
JKLMNOPQR
STUVWXYZ

Section

Subject

Topics

Hemorrhagic Shock and Encephalopathy Syndrome

Update Me

Hemorrhagic shock and encephalopathy syndrome is an extremely rare disease characterized by acute onset of severe shock, coagulopathy, encephalopathy, and hepatic and renal dysfunction in previously healthy children, resulting in death or catastrophic neurologic outcome.

Hemorrhagic shock and encephalopathy syndrome (HSES) occurs predominantly in infants aged 3 to 8 mo (median age, 5 mo) but has been reported in a 15 yr old. HSES resembles heatstroke, with extremely high temperature and multiple organ dysfunction, but the cause is unknown. Overwrapping of infants who have febrile illness has been suggested, but evidence is slim. Other theories include a reaction to intestinal or environmental toxins, pancreatic release of trypsin, or an unidentified virus or bacterium. Diffuse cerebral edema with herniation and focal hemorrhages and infarcts in the cerebral cortex and other organs are common. The lungs and myocardium are not primarily involved.

Symptoms and Signs

A prodrome of fever, upper respiratory tract symptoms, or vomiting and diarrhea occurs in most patients. The major features are an acute onset of encephalopathy, cerebral edema (manifested as seizures, coma, and hypotonia), and severe shock (ie, hypotension and poor perfusion). Other common features include hyperpyrexia (up to 43.9° C rectally), bloody or watery diarrhea, disseminated intravascular coagulation (DIC), myoglobinuria, and rhabdomyolysis.

Diagnosis

  • Laboratory testing

Similar symptoms can result from sepsis, Reye's syndrome, and hemolytic-uremic syndrome. Patients require laboratory evaluation, including blood and urine culture, ABG, CBC, electrolytes, BUN, creatinine, PT/PTT, and liver function tests. Multiple abnormalities include metabolic acidosis, elevated liver transaminases, acute renal failure, thrombocytopenia, falling Hct, leukocytosis, hypoglycemia, and hyperkalemia. Bacteriologic and viral cultures are negative. Diagnosis is by exclusion.

Prognosis

In all series, > 60% of patients died, and 70% of survivors had severe neurologic sequelae.

Treatment

  • Support measures

Treatment is entirely supportive. Infusions of large volumes of isotonic solutions and blood products (fresh frozen plasma, albumin, whole blood, packed RBCs) along with inotropic support (eg, dopamine Some Trade Names
INTROPIN
Click for Drug Monograph
, epinephrine Some Trade Names
ADRENALIN
PRIMATENE MIST
Click for Drug Monograph
) are necessary to maintain circulation. Marked temperature elevation (eg, > 39° C) requires external cooling (see Heat Illness: Treatment). Increased intracranial pressure caused by cerebral edema requires intubation and hyperventilation. DIC often progresses despite use of fresh frozen plasma.

Last full review/revision March 2009 by Elizabeth J. Palumbo, MD

Content last modified March 2009

Back to Top

Previous: Failure to Thrive

Next: Kawasaki Disease

Audio
Figures
Photographs
Tables
Videos